Evidence map›Paper›PMID 41894159›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2026

The landscape of dementia research, diagnosis, treatment, and care in Latin America.

Claudia K Suemoto, Nilton Custodio, Diego Aguilar, José A Avila-Funes, Sandra Baez, Pablo M Bagnati, Lisa L Barnes, Sonia M D Brucki, Ismael L Calandri, Paulo Caramelli and 32 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. The landscape of dementia research, diagnosis, treatment, and care in Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Claudia K SuemotoDivision of Geriatrics, University of Sao Paulo Medical School, São Paulo, Brazil.
Nilton CustodioUnidad de Investigación de Deterioro Cognitivo y Prevención de Demencia, Instituto Peruano de Neurociencias, Lima, Peru.
Diego AguilarAlzheimer's Disease International, London, UK.
José A Avila-FunesDirección de Enseñanza, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Sandra BaezDepartamento de Psicología, Universidad de los Andes, Bogotá, Colombia.
Pablo M BagnatiDepartment of Cognitive Neurology, Neuropsychiatry and Neuropsychology, Fleni Neurological Research Institute, Buenos Aires, Argentina.
Lisa L BarnesRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Sonia M D BruckiCognitive and Behavioral Neurology Unit, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Ismael L CalandriDepartment of Cognitive Neurology, Fleni, Buenos Aires, Argentina.
Paulo CaramelliBehavioral and Cognitive Neurology Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Mario Cornejo-OlivasNeurogenetics Working Group, Universidad Cientifica del Sur, Lima, Peru.
Carolina Delgado DerioDepartamento de Neurología y neurocirugía, Unidad Cerebro saludable, Hospital Clínico Universidad de Chile, Santiago, Chile.
Sergio T FerreiraInstitute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Adolfo M GarcíaCognitive Neuroscience Center (CNC), Universidad de San Andrés, Buenos Aires, Argentina.
Lea T GrinbergMayo Clinic, Jacksonville, Florida, USA.
Agustin M IbanezCognitive Neuroscience Center (CNC), Universidad de San Andrés, Buenos Aires, Argentina.
Rosario IsasiHussman Institute for Human Genomics, Institute of Bioethics and Health Policy, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA.
Sylvia E Josephy-HernándezHospital México, Caja Costarricense de Seguro Social, San José, Costa Rica.
Maria Lazo PorrasCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Jorge J Llibre-GuerraDepartment of Neurology, Washington University School of Medicine in St.Louis, St.Louis, Missouri, USA.
Juan J Llibre-RodriguezDementia Research Unit, Medical University of Havana, Havana, Cuba.
Mychael V LourencoInstitute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
B Marcela Mar MezaPrograma M-MENTE. Hospital Central Fuerza Aerea del Perú, Lima, Perú.
Joaquin MigeotGBHI, Trinity College Dublin, Dublin, Ireland.
J Jaime MirandaCRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Claudia Miranda-CastilloInstituto de Investigación en Ciencias de la Salud, Faculty of Nursing, Universidad Andres Bello, Santiago, Chile.
Catherine J MummeryDementia Research Centre, National Hospital for Neurology and Neurosurgery, Institute of Neurology, University College London, London, UK.
José F ParodiUniversidad de San Martín de Porres, Facultad de Medicina, Centro de Investigación del Envejecimiento, Lima, Perú.
Natalia Pozo CastroGlobal Brain Health Institute (GBHI), University of California, San Francisco, California, USA.
Rosa María Salinas ContrerasNational Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico city, México.
Hernando Santamaría-GarcíaGlobal Brain Health Institute (GBHI), University of California, San Francisco, California, USA.
Andrea SlachevskyGerosciences Center for Brain Health and Metabolism (GERO), Santiago, Chile.
Juliana N Souza-TalaricoCollege of Nursing, University of Iowa, Iowa City, Iowa, USA.
Ezequiel I SuraceLaboratorio de Enfermedades Neurodegenerativas, Instituto de Neurociencias-Fleni-CONICET, Buenos Aires, Argentina.
Leonel T TakadaCognitive and Behavioral Neurology Unit, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
Elena TsoyGlobal Brain Health Institute (GBHI), University of California, San Francisco, California, USA.
Martha Unaucho PilalumboGlobal Brain Health Institute (GBHI), University of California, San Francisco, California, USA.
Eduardo R ZimmerHospital Moinhos de Vento, Porto Alegre, Brazil.
Igor C FontanaUK Dementia Trials Network, Institute of Neurology, University College London, London, UK.
Simin MahinradAlzheimer's Association, Chicago, Illinois, USA.ORCID 0000-0002-5927-7130
Heather M SnyderAlzheimer's Association, Chicago, Illinois, USA.
Maria C CarrilloAlzheimer's Association, Chicago, Illinois, USA.

Funding

An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
Agencia Nacional de Investigación y DesarrolloAgencia Nacional de Promoción Científica y TecnológicaAlzheimer's AssociationANID/FondapANID/FondecytANID/FONDEFANID Millennium Science Initiative ProgramANID/PIA/ANILLOSConsejo Nacional de Desarrollo Científico y TecnológicoConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)DICYT-USACHFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de JaneiroGlobal Brain Health InstituteMulti-partner Consortium to Expand Dementia Research in Latin America (ReDLat)National Institute for Health and Care ResearchNational Institute for Translational Neuroscience (INNT-Brazil)National Institutes of AgingNIA NIH HHS R01 AG075775NIH D43 FogartyNIH HHSPilot Awards for Global Brain Health Leaders (Global Brain Health Institute, Alzheimer's Association, and Alzheimer's Society)Takeda
6 · The paper itself

Abstract

Latin America is undergoing rapid population aging alongside a rising burden of dementia. While the region holds substantial potential for dementia risk reduction, challenges remain, such as delayed diagnoses, limited access to specialized care and biomarker testing, persistent stigma, and deep-rooted structural inequities. To address these gaps and foster regionally informed solutions, the Alzheimer's Association convened the 2025 Alzheimer's Association International Conference (AAIC) Satellite Symposium in Lima, Peru, on May 14-15, in collaboration with the Global Brain Health Institute (GBHI) and the Atlantic Fellows for Equity in Brain Health. The meeting aimed to bring core elements of the global AAIC meeting to regional Latin American settings, recognizing that national and cultural contexts demand tailored approaches to dementia prevention, risk reduction, treatment and care all aimed at promoting brain health in the region. This manuscript synthesizes the symposium's key discussions, scientific advances, and opportunities for collaboration across the region.

Indexed as

Biomedical ResearchDementiaHumansLatin AmericaagingAlzheimer's diseasebrain healthdementiaLatin America

Identifiers

PMID41894159
PMCPMC13093637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.